AEON Biopharma Inc. (AEON)

Überblick Nachrichten Preisverlauf Forum Prognose

AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten

AEON Biopharma Inc. (AEON)

AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten

AEON Biopharma (NASDAQ:AEON) Trading Down 10.2% – Should You Sell? - Defense World

AEON Biopharma Holds Annual Stockholders Meeting - TipRanks

AEON Biopharma, Inc. (NASDAQ:AEON) Short Interest Update - Defense World

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times

AEON Biopharma Expands Team with 100K+ Stock Awards: Inside the Biotech's Latest Hiring Move - Stock Titan

Aeon Biopharma Reports Positive Q1 2025 Earnings - TipRanks

AEON Biopharma Releases New Corporate Presentation - TipRanks

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - The Manila Times

AEON Biopharma to Present Corporate Overview at Aegis Capital Corp. 2025 Virtual Conference - Nasdaq

AEON Biopharma Unveils Next-Gen Botulinum Toxin Therapies: CEO Details Multi-Indication Pipeline - Stock Titan

AEON Biopharma Advances Biosimilar Product Development and Appoints New CEO - Nasdaq

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - The Manila Times

New AEON CEO Targets $3.3B Botox Market with FDA-Ready Biosimilar Development Plan - Stock Titan

AEON Biopharma (AEON) Projected to Post Quarterly Earnings on Tuesday - Defense World

Closing Bell Recap: AEON Biopharma Inc (AEON) Ends at 0.75, Reflecting a -11.76 Downturn - DWinneX

AEON Biopharma Inc (AMEX: AEON) Stock: Investors Need To Know This - Stocksregister

Is AEON Biopharma Inc’s (AMEX:AEON) Stock On The Decline? - Stocksregister

AEON Biopharma gets NYSE American nod for compliance plan - Investing.com Australia

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - The Manila Times

AEON Biopharma gets NYSE American nod for compliance plan By Investing.com - Investing.com India

AEON Biopharma Says NYSE American Accepts Plan to Regain Compliance - marketscreener.com

AEON Biopharma Receives Acceptance from NYSE American to Regain Compliance with Listing Standards - Nasdaq

NYSE American Grants AEON Biopharma 2-Year Lifeline to Meet Listing Requirements - Stock Titan

What was AEON Biopharma Inc (AEON)’s performance in the last session? - uspostnews.com

Analyzing the Impact of Earnings Reports on AEON Biopharma Inc Inc. (AEON) Price Performance - investchronicle.com

Who’s Hired? Botox Biosimilar Developer Aeon Takes CEO From Rival Revance - insights.citeline.com

AEON Biopharma, Inc. Announces Executive Changes, Effective as of April 4, 2025 - marketscreener.com

AEON Biopharma announces CEO appointment - MSN

AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer - The Manila Times

AEON Biopharma names Rob Bancroft as new CEO By Investing.com - Investing.com South Africa

Aeon Biopharma Names Robert Bancroft CEO - marketscreener.com

AEON Biopharma Appoints New CEO Robert Bancroft - TipRanks

Aeon Biopharma (AEON) Appoints Rob Bancroft as New CEO | AEON Stock News - GuruFocus

AEON Biopharma Appoints Rob Bancroft as CEO - MarketWatch

AEON Biopharma names Rob Bancroft as new CEO - Investing.com

AEON Biopharma (NASDAQ:AEON) Trading 2.5% Higher – Time to Buy? - Defense World

AEON Biopharma announces new interim CEO and CFO By Investing.com - Investing.com Australia

AEON Biopharma Appoints Jost Fischer as Interim CEO - TipRanks

AEON Biopharma announces new interim CEO and CFO - Investing.com

Aesthetic Medicine Powerhouse: BOTOX Veteran Takes Helm at Jeune Aesthetics - Stock Titan

AEON Biopharma Inc (AEON) Stock: The Story of a 52-Week Stock Range - investchronicle.com

AEON Biopharma’s Strategic Progress and Financial Turnaround - TipRanks

Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1 - NewsBreak: Local News & Alerts

AEON Biopharma announces leadership change amid growth strategy By Investing.com - Investing.com Philippines

Aeon Biopharma CEO to Step Down Next Week - Orange County Business Journal

AEON Biopharma CEO Marc Forth to Resign; Board Chairman Jost Fischer Is Interim CEO - MarketScreener

AEON Biopharma announces leadership change amid growth strategy - Investing.com

Ähnlich wie AEON